Stacey is a Technical Advisor that prepares and prosecutes patent applications for clients in the biotechnology and pharmaceutical industries. She has worked with clients in a wide range of technology areas in the life sciences including pharmaceutical formulations, small molecules, antibodies, protein therapeutics, viral therapeutics, and therapeutic methods in molecular and cellular biology.
Prior to joining Haley Guiliano, she interned and consulted for CURE Pharmaceutical where she assisted with prior art searches, patentability, and patent applications related to formulations and methods of manufacturing.
Prior to pursuing her career in intellectual property, Stacey was a Postdoctoral Scientist at Cedars-Sinai Medical Center researching various treatments for breast cancer and mechanisms that drive triple-negative breast cancer progression. Stacey earned her Ph.D. from Case Western University where she studied the molecular mechanism of hepatic alpha-tocopherol (vitamin E) transport. Her thesis study revealed that alpha-tocopherol and membrane lipids dynamically affect the localization of the alpha-tocopherol transfer protein (TTP) localization, and mutations in TTP affect protein-lipid interaction. Previous to pursuing her doctoral degree, Stacey earned her B.S. in Biotechnology from Rutgers University. As a George H. Cook Honors Program scholar, she performed undergraduate research studying vitamin A metabolism in the prostate epithelium.